Benzodiazepine use, reduction and withdrawal Mental and Behavioural Disorders
Conditions
Interventions
Patients were randomised to one of three groups, comparing two strategies for the reduction of chronic bendzodizepine and a control group:
1. Structured educational intervention: 1 educational intervi
Sponsors
Health Service of the Balearic Islands (Servei de Salut de les Illes Balears [IB-salut]) (Spain)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients between 18 and 80 years 2. Recorded history of benzodiazepine consumption or an analogue at least 5 times a week for at least six months 3. A minimum of 6 months prescription of a benzodiazepine or similar
Exclusion criteria
Exclusion criteria: 1. Patients with severe anxiety or depressive disorder, psychotic disorder, severe personality disorder, and/or psychiatric monitoring 2. Patients with cognitive impairment, terminal illness or serious medical conditions, illegal drug use or abuse alcohol, inability to sign informed consent 3. Institutionalised patients 4. Patients with exacerbation of symptoms of anxiety/depression whose doctor considers that the withdrawal of a benzodiazepine can be harmful at this time 5. Patients with limited capacity for understanding 6. Patients that have participated in a clinical research study during the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Benzodiazepine use at 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Anxiety and Depression Scale 2. Quality of Sleep Scale 3. Alcohol consumption Outcomes will be measured at baseline, 6 and 12 months. | — |
Countries
Spain
Outcome results
None listed